MatriSys Bioscience: Funding, Investors & Team (Sep 2026)
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.
MatriSys Bioscience has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Mar 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MatriSys Bioscience Company Profile and Key Stats
Latest funding round on record: Mar 2021.
MatriSys Bioscience Funding Rounds
MatriSys Bioscience Founders and Leadership Team
No contact details are on record for this team yet.
MatriSys Bioscience Funding Compared to Other Biotechnology Startups
MatriSys Bioscience's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MatriSys Bioscience in Biotechnology and La Jolla
Companies Similar to MatriSys Bioscience
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
MatriSys Bioscience Funding FAQs
What does MatriSys Bioscience do?
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.
How much funding has MatriSys Bioscience raised?
MatriSys Bioscience has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Mar 2021.
When did MatriSys Bioscience last raise funding?
MatriSys Bioscience's most recent funding round on record is an undisclosed round of $3.0M, announced in Mar 2021.
Who is the CEO of MatriSys Bioscience?
Philippe Calais is listed as CEO at MatriSys Bioscience.
Where is MatriSys Bioscience headquartered?
MatriSys Bioscience is based in La Jolla, California, United States.
How many employees does MatriSys Bioscience have?
MatriSys Bioscience is in the 1-10 employee band.
How does MatriSys Bioscience's funding compare to other Biotechnology startups?
MatriSys Bioscience's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's MatriSys Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MatriSys Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.